Telcon Inc (KQ:200230) — Market Cap & Net Worth
Market Cap & Net Worth: Telcon Inc (200230)
Telcon Inc (KQ:200230) has a market capitalization of $17.45 Million (₩25.75 Billion) as of June 18, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #25574 globally and #1866 in its home market, demonstrating a -24.84% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Telcon Inc's stock price ₩360.00 by its total outstanding shares 71513985 (71.51 Million). Review total liabilities of Telcon Inc to assess the company's total debt and financial obligations.
Telcon Inc Market Cap History: 2015 to 2026
Telcon Inc's market capitalization history from 2015 to 2026. Data shows change from $59.13 Million to $17.45 Million (-6.53% CAGR).
Index Memberships
Telcon Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$276.99 Billion | 0.01% | #1010 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$276.99 Billion | 0.01% | #1010 of 1384 |
Weight: Telcon Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Telcon Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Telcon Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Telcon Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $207.18 Million | $29.84 Billion | -$3.44 Billion | 0.01x | N/A |
| 2017 | $722.11 Million | $41.15 Billion | -$16.44 Billion | 0.02x | N/A |
| 2018 | $401.28 Million | $57.71 Billion | -$13.75 Billion | 0.01x | N/A |
| 2019 | $235.54 Million | $56.59 Billion | -$52.65 Billion | 0.00x | N/A |
| 2020 | $293.69 Million | $33.14 Billion | -$43.05 Billion | 0.01x | N/A |
| 2021 | $141.76 Million | $37.84 Billion | -$23.10 Billion | 0.00x | N/A |
| 2022 | $49.19 Million | $27.83 Billion | -$42.08 Billion | 0.00x | N/A |
| 2023 | $42.31 Million | $36.31 Billion | $13.91 Billion | 0.00x | 0.00x |
| 2024 | $284.48 Million | $37.87 Billion | -$26.32 Billion | 0.01x | N/A |
| 2025 | $44.44 Million | $43.16 Billion | -$11.46 Billion | 0.00x | N/A |
Competitor Companies of 200230 by Market Capitalization
Companies near Telcon Inc in the global market cap rankings as of June 18, 2026.
Key companies related to Telcon Inc by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #513 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #560 globally with a market cap of $48.78 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #631 globally with a market cap of $43.86 Billion USD ( CN¥299.75 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #634 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #513 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #560 | GALDERMA GROUP AG | NYSE:GALDY | $48.78 Billion | $43.27 |
| #631 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $43.86 Billion | CN¥46.99 |
| #634 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €13.30 |
Telcon Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Telcon Inc's market cap moved from $59.13 Million to $ 17.45 Million, with a yearly change of -6.53%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | ₩17.45 Million | -60.74% |
| 2025 | ₩44.44 Million | -84.38% |
| 2024 | ₩284.48 Million | +572.39% |
| 2023 | ₩42.31 Million | -13.99% |
| 2022 | ₩49.19 Million | -65.30% |
| 2021 | ₩141.76 Million | -51.73% |
| 2020 | ₩293.69 Million | +24.69% |
| 2019 | ₩235.54 Million | -41.30% |
| 2018 | ₩401.28 Million | -44.43% |
| 2017 | ₩722.11 Million | +248.54% |
| 2016 | ₩207.18 Million | +250.41% |
| 2015 | ₩59.13 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 18th, 2026 the market cap of Telcon Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $17.45 Million USD |
| MoneyControl | $17.45 Million USD |
| MarketWatch | $17.45 Million USD |
| marketcap.company | $17.45 Million USD |
| Reuters | $17.45 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Telcon Inc
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.